Arkansas Business Times
SEE OTHER BRANDS

The latest business and economy news from Arkansas

Gynecological Devices Market Size Soars USD 25.36 Billion by 2034 | Towards Healthcare

The global gynecological devices market is valued at USD 11.99 billion in 2025 and is projected to reach USD 25.36 billion by 2034, expanding at a CAGR of 8.68% during the forecast period.

Ottawa, Sept. 08, 2025 (GLOBE NEWSWIRE) -- The global gynecological devices market size was estimated at USD 11.03 billion in 2024 and is expected to grow to USD 25.36 billion by 2034, registering a CAGR of 8.68%, according to a study by Towards Healthcare, a sister company of Precedence Research.

The growth of the market is driven by the increasing incidence of disorders and advancements in minimally invasive procedures, which fuel the growth.

The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.towardshealthcare.com/download-sample/5496

Key Takeaways

  • North America dominated the global market share by 39% in 2024.
  • Asia-Pacific is projected to host the fastest-growing gynecological devices market in the coming years.
  • By product, the surgical devices segment held a dominant presence in the market in 2024 and is expected to grow at the highest rate during 2025-2034.
  • By product, the diagnostic imaging systems segment is predicted to witness significant growth in the market over the forecast period.
  • By end-use, the hospitals & clinics segment led the global market in 2024.
  • By end-use, the ambulatory surgical centers (ASCs) segment is anticipated to grow with the highest CAGR in the market during the studied years.

Market Overview & Potential

Gynecological devices are medical devices specifically designed for the care and treatment of women’s health. These devices aid in the diagnosis, treatment, and prevention of several gynecological disorders. Some common examples of gynecological devices include forceps & clamps, cervical dilators, vaginal speculums, scissors, and retractors. These devices are used for a wide range of applications, from routine check-ups and prenatal care to surgical procedures. They are also used for managing gynecological cancers. These devices enable healthcare providers to diagnose conditions earlier, monitor pregnancies more effectively, and perform surgeries with greater precision and less invasiveness.

What is the Growth Potential Responsible for The Growth of The Gynecological Devices Market?

The growth of the market is driven by the growing incidence of disorders, advances in minimally invasive procedures, technological advances, nets, and innovations like AI-enabled ultrasound imaging systems, 3D endoscopes, and wireless endoscopic cameras, which help improve diagnostic accuracy and also help in expanding treatment options, which fuels the growth of the market. Other key growth drivers are the increased demand for advanced devices and improved patient outcomes, which further boost the growth and expansion of the market.

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

What Are the Growing Trends Associated with the Gynecological Devices Market?

Research and Development (R&D):

  • Manufacturers are investing in R&D to create efficient devices for accurate diagnoses, minimized operating times, and durable, autoclavable instruments.

Growing Awareness:

  • Increased awareness among women about the importance of regular check-ups is also positively impacting the market.

Increasing Incidence of Gynecological Conditions:

  • A greater number of women are being diagnosed with conditions such as cervical cancer, extended bleeding, and polycystic ovary syndrome, creating higher demand for diagnostic and therapeutic devices.

Shift Towards Minimally Invasive (MI) Procedures:

  • The benefits of MI surgeries, such as quicker patient recovery and better cosmetic outcomes, are leading to their increased use and the development of related devices.

What Is the Growing Challenge in the Gynecological Devices Market?

The key challenges that hinder the growth of the market are the high costs of advanced devices, which limit their purchase, limited access in underserved areas, reimbursement issues, regulatory and safety concerns, strict regulatory approvals, regulatory disparity, device safety, low awareness, cultural stigma, and a shortage of skilled professionals, which limit the growth and expansion of the market.

Regional Analysis

How Did North America Dominate the Gynecological Devices Market in 2024?

North America dominated the global market share by 39% in 2024. North America remains a leading region in the gynecological devices market due to well-established healthcare infrastructure, high adoption of advanced technologies, and significant investments in women’s health. The rising prevalence of gynecological disorders, supportive reimbursement policies, and the presence of major device manufacturers strengthen regional growth. Additionally, growing awareness and screening programs for cancers and reproductive health create a strong demand for both surgical and diagnostic gynecological devices.

Become a valued research partner with us - https://www.towardshealthcare.com/schedule-meeting

What Made the Asia Pacific Significantly Grow in The Gynecological Devices Market In 2024?

Asia-Pacific is projected to host the fastest-growing gynecological devices market in the coming years. Asia Pacific is witnessing rapid expansion in the gynecological devices market, supported by growing healthcare investments, rising awareness of women’s health, and increasing prevalence of gynecological diseases. Expanding hospital networks, rising demand for minimally invasive procedures, and the affordability of diagnostic imaging systems further drive adoption. Countries in this region are focusing on early disease detection and improved maternal health, fueling demand for advanced gynecological surgical and imaging devices.

Segmental Insights

By Product,

The surgical devices segment held a dominant presence in the market in 2024 and is expected to grow at the highest rate during 2025-2034. Surgical devices hold a significant share of the gynecological devices market, covering instruments used in minimally invasive surgeries, endoscopy, hysteroscopy, and laparoscopy. Increasing demand for advanced tools with precision, safety, and reduced recovery times drives adoption. Rising cases of gynecological disorders such as fibroids, endometriosis, and cancers have further boosted the need for reliable surgical solutions. Technological innovation continues to enhance efficiency in both routine and complex procedures.

The diagnostic imaging systems segment is predicted to witness significant growth in the market over the forecast period. Diagnostic imaging systems are crucial in the early detection and monitoring of gynecological conditions. Devices such as ultrasound systems, MRI, and other imaging tools provide detailed visualization for accurate diagnosis. Increasing emphasis on preventive healthcare, advancements in 3D and portable imaging solutions, and rising awareness of women’s health have spurred growth. Their role in detecting cancers, reproductive health issues, and pregnancy-related complications ensures steady market demand.

By End-Use,

The hospitals & clinics segment led the global market in 2024. Hospitals and clinics dominate the adoption of gynecological devices due to their advanced infrastructure and availability of skilled professionals. These facilities rely heavily on both surgical devices and diagnostic imaging systems to provide comprehensive women’s healthcare. The high patient inflow, preference for minimally invasive procedures, and integration of advanced imaging technologies strengthen the position of this segment, making hospitals and clinics the primary end users globally.

The ambulatory surgical centers (ASCs) segment is anticipated to grow with the highest CAGR in the market during the studied years. Ambulatory surgical centers are rapidly emerging as preferred venues for gynecological procedures. Their advantages include cost-effectiveness, shorter waiting times, and patient convenience. Equipped with surgical and diagnostic devices, these centers cater to minimally invasive treatments, particularly hysteroscopy and laparoscopy. Growing preference for outpatient care, supported by technological advancements in portable and compact devices, is driving the adoption of gynecological devices across ambulatory surgical centers worldwide.

Get the latest insights on life science industry segmentation with our Annual Membership: https://www.towardshealthcare.com/get-an-annual-membership

Recent Developments

  • In September 2024, Olympus announced the launch of a novel 4K camera head, CH-S700-08-LB, for endoscopic urology and gynecology procedures. The camera is compatible with the Visera Elite III video system and is available in Europe. The company aims to market in Japan, Hong Kong, and Singapore.
  • In April 2024, GE Healthcare announced the launch of ultrasound systems, Voluson Signature 20 and 18, for women’s health imaging. The system is integrated with AI and other advanced tools, facilitating faster examination and delivering a clearer picture of various conditions impacting women’s health.

Gynecological Devices Market Key Players

  • Bioteque America
  • Boston Scientific
  • CooperSurgical, Inc.
  • GE Healthcare
  • Gynemed
  • Gynex Corporation
  • Gynocare Services Pvt. Ltd.
  • Medtronic plc
  • Olympus Corporation
  • Samsung Medison
  • Sonio SAS
  • Stryker Corporation
  • Veol Medical Technologies

Browse More Insights of Towards Healthcare:

The global orthopedic 3D printing devices market is valued at US$ 2.48 billion in 2024, rising to US$ 2.75 billion in 2025, and is expected to surpass US$ 6.87 billion by 2034, expanding at a CAGR of 11.24% during 2025–2034.

The cell and gene therapy drug delivery devices market is witnessing steady momentum and is anticipated to post significant revenue growth, potentially advancing into the hundreds of millions of dollars throughout the forecast period of 2025–2034.

The global IoT medical devices market is projected at US$ 82.45 billion in 2024, increasing to US$ 105.54 billion in 2025, and surging to nearly US$ 971.27 billion by 2034, supported by a strong CAGR of 28% from 2025 to 2034.

The global point-of-care molecular diagnostics market stood at US$ 4.05 billion in 2024, expanded to US$ 4.48 billion in 2025, and is forecasted to reach around US$ 11.03 billion by 2034, advancing at a CAGR of 10.45% over the same period.

The oral proteins and peptides market is assessed at US$ 8.05 billion in 2024, growing to US$ 9.36 billion in 2025, and on track to achieve approximately US$ 36.35 billion by 2034, fueled by a CAGR of 16.34% between 2025 and 2034.

The endoscopic submucosal dissection (ESD) market was worth US$ 460 million in 2024, is projected to reach US$ 498.41 million in 2025, and expected to hit US$ 1.02 billion by 2034, progressing at a CAGR of 8.35% during the forecast timeline.

The anticoagulation monitoring devices market recorded US$ 1.55 billion in 2024 and is anticipated to double to about US$ 3.13 billion by 2034, growing at a CAGR of 7.24% from 2025 onward.

The global ophthalmology devices market generated US$ 7.51 billion in 2024, is estimated to grow to US$ 7.89 billion in 2025, and forecasted to cross US$ 12.39 billion by 2034, with a CAGR of 5.14% between 2025 and 2034.

The global urology devices market stood at US$ 16.35 billion in 2024, expanded to US$ 17.61 billion in 2025, and is projected to reach around US$ 34.42 billion by 2034, registering a CAGR of 7.74% over the forecast years.

The pediatric devices market is set for promising growth, with revenues anticipated to climb steadily into the hundreds of millions of dollars throughout the 2025–2034 period.

Segments Covered in The Report

By Product

  • Surgical Devices
    • Gynecological Endoscopy Devices
      • Hysteroscope
      • Colposcope
      • Resectoscope
      • Laparoscope
    • Endoscopic Imaging Systems
      • Endometrial Ablation Devices
      • Hydrothermal Ablation Devices
      • Radiofrequency Ablation Devices
      • Balloon Ablation Devices
      • Others (Microwave, Laser)
    • Fluid Management Systems
    • Female Sterilization/Contraceptive Devices
      • Permanent Birth Control
      • Intra Uterine Devices (IUD)
      • Intravaginal Rings
      • Subdermal Contraceptive Implants
  • Diagnostic Imaging Systems
  • Handheld Instruments
    • Vaginal Speculum
    • Tenaculum
    • Curettes
    • Trocars Market
    • Biopsy Forceps
    • Others

By End-Use

  • Hospitals & Clinics
  • Ambulatory Surgical Centers (ASCs)

By Region

  • North America
    • U.S.
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Thailand
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait

Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/price/5496

Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.

Access the Dashboard: https://www.towardshealthcare.com/access-dashboard

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

Europe Region: +44 778 256 0738

North America Region: +1 8044 4193 44

APAC Region: +91 9356 9282 04

Web: https://www.towardshealthcare.com

Our Trusted Data Partners

Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire

Find us on social platforms: LinkedInTwitterInstagram | Medium | Pinterest


Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions